Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACTEL: Treatment of Hyperlactatemia in Acute Circulatory Failure Based on Analysis of CO2
NCT05032521Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hyperlactatemia and acute circulatory failure (2 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Number of patients with a lactate clearance of more than 10% at 2 hours. Started Nov 2021; status: completed.
02
Conditions
hyperlactatemiaacute circulatory failure
Beyond the preview
Go deeper on NCT05032521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05032521.